Home
About
FAQ
History (4)
Biotinidase Deficiency
Safe Step Act: does it undermine step therapy?
Skin manifestations of outpatient adverse drug events in the United States: a national analysis.
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Safe Step Act: does it undermine step therapy?
Bashyam AM, Williford PM, Feldman SR. Safe Step Act: does it undermine step therapy? Dermatol Online J. 2020 Apr 15; 26(4).
View in:
PubMed
subject areas
Cost Control
Employee Retirement Income Security Act
Health Care Costs
Health Expenditures
Insurance, Health
United States
authors with profiles
Steven R. Feldman MD, PhD